CSHR
Price
$4.03
Change
-$0.03 (-0.74%)
Updated
Oct 22 closing price
Capitalization
531.07M
27 days until earnings call
Intraday BUY SELL Signals
SCHW
Price
$91.46
Change
-$0.18 (-0.20%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
158.48B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSHR vs SCHW

CSHR vs SCHW Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSHR vs. SCHW commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHR is a Hold and SCHW is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSHR with price predictions
Oct 22, 2026

CSHR's Stochastic Oscillator is remaining in oversold zone for 16 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CSHR's RSI Oscillator exited the oversold zone, 13 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

Following a +5.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSHR advanced for three days, in 41 of 77 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

CSHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CSHR as a result. In 33 of 61 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.

The Moving Average Convergence Divergence Histogram (MACD) for CSHR turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 21 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

CSHR moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CSHR crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for CSHR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.172) is normal, around the industry mean (3.532). P/E Ratio (4.429) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.328) settles around the average of (7.708) among similar stocks. P/S Ratio (2.521) is also within normal values, averaging (16.763).

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CSHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
a Summary for SCHW with price predictions
Oct 22, 2026

SCHW's Stochastic Oscillator is staying in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SCHW's RSI Indicator exited the oversold zone, 24 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

Following a +2.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHW advanced for three days, in 185 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

SCHW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SCHW turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 24 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.

SCHW moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SCHW crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

The Aroon Indicator for SCHW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. SCHW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCHW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.607) is normal, around the industry mean (3.532). P/E Ratio (16.601) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.832) is also within normal values, averaging (0.809). Dividend Yield (0.014) settles around the average of (7.708) among similar stocks. P/S Ratio (7.148) is also within normal values, averaging (16.763).

FUNDAMENTALS RATINGS
SCHW: Fundamental Ratings
SCHW
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
5
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSHRSCHW
RSI
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
54%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
60%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CSHR: $4.03 vs. SCHW: $91.64)
Brand notoriety: CSHR: Not notable vs. SCHW: Notable
Both companies represent the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: CSHR: 77% vs. SCHW: 95%
Market capitalization -- CSHR: $531.07M vs. SCHW: $158.48B
CSHR [@Investment Banks/Brokers] is valued at $531.07M. SCHW’s [@Investment Banks/Brokers] market capitalization is $158.48B. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $293.71B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSHR’s FA Score shows that 0 FA rating(s) are green while SCHW’s FA Score has 1 green FA rating(s).

  • CSHR’s FA Score: 0 green, 5 red.
  • SCHW’s FA Score: 1 green, 4 red.
According to our system of comparison, SCHW is a better buy in the long-term than CSHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSHR’s TA Score shows that 4 TA indicator(s) are bullish while SCHW’s TA Score has 4 bullish TA indicator(s).

  • CSHR’s TA Score: 4 bullish, 6 bearish.
  • SCHW’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SCHW is a better buy in the short-term than CSHR.

Price Growth

CSHR (@Investment Banks/Brokers) experienced а -1.47% price change this week, while SCHW (@Investment Banks/Brokers) price change was -5.33% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.38%. For the same industry, the average monthly price growth was -17.06%, and the average quarterly price growth was -13.36%.

Reported Earning Dates

CSHR is expected to report earnings on Nov 18, 2026.

SCHW is expected to report earnings on Jan 19, 2027.

Industries' Descriptions

@Investment Banks/Brokers (-5.38% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
CSHR
Daily Signal:
Gain/Loss:
SCHW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SCHW and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCHW has been closely correlated with RJF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCHW jumps, then RJF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCHW
1D Price
Change %
SCHW100%
-0.22%
RJF - SCHW
72%
Closely correlated
+2.25%
LPLA - SCHW
68%
Closely correlated
-0.68%
NDAQ - SCHW
62%
Loosely correlated
+7.47%
MORN - SCHW
57%
Loosely correlated
+4.46%
SPGI - SCHW
56%
Loosely correlated
+2.24%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGRY15.900.50
+3.25%
Surgery Partners
MSS1.270.02
+1.60%
Maison Solutions Inc
GKOS176.69-0.16
-0.09%
Glaukos Corp
GECC4.80-0.11
-2.24%
Great Elm Capital Corp
ALLO1.25-0.08
-6.02%
Allogene Therapeutics